Treatment of VTE in acutely ill children has been largely based on adult data but new paediatric research is showing rivaroxoban is effective in reducing thrombotic burden without increased bleeding. Professor Christoph Male, from the department of paediatrics at the Medical University of Vienna, presented late-breaking findings from the EINSTEIN-Junior phase 3 trial of rivaroxaban ...
Positive DOAC data for treating VTE in children
By Mardi Chapman
25 Jul 2019